Living Tissue Management - Markets
Tulip BioMed’s potential impact on the market is far more than merely cosmetic. In a parallel with the example of Becton Dickinson, which grew from a $10 million per year company to over $4 billion as it developed the first disposable syringe and needle to address new FDA requirements, we hope to see similarly aggressive growth for Tulip BioMed’s line of cannula products.
While our instruments may have the most profound impact on the fields of plastic and cosmetic surgeries, their benefits are far-reaching into other areas as well. We are rapidly establishing a quality reputation in cosmetic, plastic, ophthalmic, and orthopedic surgery markets while stem cell and other living tissue management procedures evolve.
- Plastic and Cosmetic Surgeries – With a strong legacy in providing quality instruments for this market, Tulip BioMed now provides a safer and higher performing alternative, especially for tissue transfer and re-injection in microfacial procedures.
- Orthopedic Surgery – Tulip Disposable cannulas are ideal for the injection of bone cement in orthopedic procedures, as well as collecting cells from the bone matrix for modification and re-injection.
- Urinary Incontinence – In urinary incontinence caused by a weak bladder outlet, using our cannulas to place some support (fat) around the outlet may help control the incontinence.
- Fine Needle Aspiration Biopsy – Collection or harvesting of tissue with our cannulas can support clinical diagnoses based on the pathology or anatomy of tissue samples.
- Stem Cell Procedures – As a burgeoning market (with a potential size over $1 billion), stem cell extraction and re-injection would place a premium on instruments that maintain the sanctity of healthy cells throughout the procedure.
The net result of all this technology? Innovative and exclusive product design that makes for better, safer, and easier procedures.
|
